AGTC

About:

AGTC is a biotechnology company conducting human clinical trials of AAV-based gene therapies for the treatment of rare diseases.

Website: http://agtc.com

Twitter/X: agtc_

Top Investors: SR One, InterWest Partners, OUP (Osage University Partners), Alta Partners, Intersouth Partners

Description:

Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patient’s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.